Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...

"Hearst Magazines and AOL may earn commission or revenue on some items through these links." You don’t need us to tell you ...

Eli Lilly (NYSE: LLY) is currently the leader in the weight loss market. Sales of the company's anti-obesity medicine, ...

The country star says he was ‘scared' to step on the scale after gaining 12 pounds following the holidays and an injury, but ...

If you are trying to lose weight, you need to be careful about which supplements you chose since some supplements can cause ...

GLP-1 medications that suppress appetite are allowing people to better manage diabetes and obesity. As weight-loss drug ...

The FDA has approved the second GLP-1 pill for overweight and obesity. How does it compare to the Wegovy oral pill?

Demand for weight loss drugs is ballooning across the U.S. — and Amazon wants in. The Seattle-based tech giant launched its ...

There are a few important things to consider.

FRANKFURT, April 28 (Reuters) - Boehringer Ingelheim said on Tuesday its experimental obesity drug led to average weight loss ...

Boehringer Ingelheim GmbH said patients using its experimental obesity shot lost 16.6% of their body weight in a large study, ...